Drew Fromkin
Chief Executive Officer
30+ years leadership in public & private healthcare companies. He serves as Vant Portfolio Operating Partner for Roivant Sciences, Inc. (ROIV) and on the board of Board of Immunovant, Inc. (IMVT).
Chief Executive Officer
30+ years leadership in public & private healthcare companies. He serves as Vant Portfolio Operating Partner for Roivant Sciences, Inc. (ROIV) and on the board of Board of Immunovant, Inc. (IMVT).